Table 2

Clinical characteristics of participants from the Beer-Sheva subcohorts from the Beer-Sheva biobank

Subcohort 1, matched pairsSubcohort 2, validationSubcohort 3, patients with diabetes vs. patients without diabetesSubcohort 4, ATM lipid accumulaion
n16 (8 matched pairs)48 (including 11 matched pairs)3524
Age (years)40.75 ± 8.940.7 ± 1138.7 ± 10.141.2 ± 14.5
Sex (% female)62646858
BMI (kg/m2)41.6 ± 541.9 ± 941.2 ± 3.734.7 ± 6.1*
FPG (mg/dL)97 ± 22116.85 ± 39116.6 ± 2994 ± 32
TG (mg/dL)158.8 ± 65.8150.76 ± 63144 ± 42159 ± 59
LDL (mg/dL)116.5 ± 28125.2 ± 30114.5 ± 24103.2 ± 22
HDL (mg/dL)41.6 ± 8.742.1 ± 6.242.3 ± 940 ± 14.5
Systolic BP (mmHg)146 ± 17139.1 ± 20139 ± 12.3124.2 ± 13.07
  • Values are means ± SD. Participants in the subcohorts are not overlapping. Studies 1–3 include patients with obesity (i.e., BMI ≥30 kg/m2). *This study included participants with overweight (i.e., BMI ≥25 kg/m2). BP, blood pressure. FPG, fasting plasma glucose.